All
FDA, European agencies extend confidentiality arrangements
December 6th 2005Washington--The Food and Drug Administration (FDA), the European Commission (EU) and the European Medicines Agency (EMA) have agreed to a five-year extension of their confidentiality arrangements regarding medicines for human and veterinary use.
Antares partners with derm firm to adapt delivery platform
December 6th 2005Exton, Pa.--Antares Pharma and a firm specializing in treatments for dermatological conditions have signed a feasibility development agreement to develop and apply Antares' transdermal delivery ATD? gel platform to formulate an active compound contained in a topical skin product.
Counterfeit drug trade draws congressional scrutiny
December 1st 2005Counterfeit prescription drugs pose a "potentially serious health threat" in the United States — one that can result in serious or deadly consequences for patients because of unscrupulous acts of profiteers who take advantage of a lack of uniform regulation and enforcement.
Surgeon screens potential face transplant recipients
December 1st 2005Cleveland - With 20 years' experience in working withcomposite tissue allograft transplants, Maria Siemionow, M.D.,Ph.D., tells Dermatology Times she has laid the groundwork for whatlikely will be the world's first human face transplant.
Counterfeit drug trade draws congressional scrutiny
December 1st 2005Counterfeit prescription drugs pose a "potentially serious health threat" in the United States — one that can result in serious or deadly consequences for patients because of unscrupulous acts of profiteers who take advantage of a lack of uniform regulation and enforcement.
Using biologics to treat psoriasis
December 1st 2005Las Vegas — As dermatologists continue to incorporate biologics into their treatment approaches, Alan Menter, M.D., of Baylor University Medical Center, Dallas, and president of the International Psoriasis Council, discusses the efficacy and safety of five currently available biologic agents and the importance of transitioning patients onto these drugs without flare.
Urticaria: Reviewing the basics
December 1st 2005National report — Categorizing urticaria and following up with effective treatment can prove to be very challenging to the clinician, according to Aniko Kobza Black, M.D., attending physician, St. John's Institute of Dermatology and St. Thomas Hospital, London.
Unnecessary walking costs you time, money
December 1st 2005Time and motion studies aren't just for assembly line workers; dermatology practices can benefit, too. Unnecessary walking is a prime time-waster in many physician practices. Don't think it's happening in your practice? Put on a pedometer tomorrow when your first clinic starts. At the end of the day you'll be amazed at how far you've walked.
Silicone effective for acne scarring; side effects limited
December 1st 2005Atlanta — Although many physicians remain skeptical about the use of injectable silicone, Stephen Mandy, M.D., of Miami discussed the benefits of using the synthetic polymer to treat acne scarring at the American Society of Dermatologic Surgery Meeting here.
Antiviral drugs effectively manage herpes infection in children, adults
December 1st 2005National report — Children infected with herpes simplex virus can be safely treated with valacyclovir — an antiviral commonly prescribed to treat adult herpes infection, according to research by Richard F. Jacobs, M.D., F.A.A.P., a pediatric infectious disease specialist at Arkansas Children's Hospital.